loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of AM20030018 NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Curia New York, Inc. (2)

02 MAEDA INC (1)

filter

01 VORINOSTAT (1)

02 Vorinostat Coarse (1)

03 Vorinostat Fine (1)

filter

01 U.S.A (2)

02 Blank (1)

URL Supplier Web Content
Vorinostat Fine
POWDER (55kg/55kg)
BULK INGREDIENT FOR ...
65392-3102
2006-10-06
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Vorinostat Coarse
POWDER (55kg/55kg)
BULK INGREDIENT
65392-3101
2006-10-06
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

MAEDA INC

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
VORINOSTAT
POWDER (1g/g)
BULK INGREDIENT
86184-423
2023-08-09
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 149647-78-9 / Vorinostat API manufacturers, exporters & distributors?

Vorinostat manufacturers, exporters & distributors 1

13

PharmaCompass offers a list of Vorinostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vorinostat manufacturer or Vorinostat supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vorinostat manufacturer or Vorinostat supplier.

PharmaCompass also assists you with knowing the Vorinostat API Price utilized in the formulation of products. Vorinostat API Price is not always fixed or binding as the Vorinostat Price is obtained through a variety of data sources. The Vorinostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Vorinostat

Synonyms

149647-78-9, Saha, Suberoylanilide hydroxamic acid, Zolinza, N-hydroxy-n'-phenyloctanediamide, N1-hydroxy-n8-phenyloctanediamide

Cas Number

149647-78-9

Unique Ingredient Identifier (UNII)

58IFB293JI

About Vorinostat

A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.

AM20030018 Manufacturers

A AM20030018 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AM20030018, including repackagers and relabelers. The FDA regulates AM20030018 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AM20030018 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of AM20030018 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

AM20030018 Suppliers

A AM20030018 supplier is an individual or a company that provides AM20030018 active pharmaceutical ingredient (API) or AM20030018 finished formulations upon request. The AM20030018 suppliers may include AM20030018 API manufacturers, exporters, distributors and traders.

click here to find a list of AM20030018 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

AM20030018 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AM20030018 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for AM20030018 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture AM20030018 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain AM20030018 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AM20030018 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of AM20030018 suppliers with NDC on PharmaCompass.

AM20030018 Manufacturers | Traders | Suppliers

AM20030018 Manufacturers, Traders, Suppliers 1
28

We have 1 companies offering AM20030018

Get in contact with the supplier of your choice:

  1. Curia
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY